documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

15 rows where agency_id = "FDA" and docket_id = "FDA-2003-D-0030" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

agency_id 1

  • FDA · 15 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2003-D-0030-0013 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Transcript of January 9, 2007 Workshop Other TR-Transcript 2007-03-21T04:00:00Z 2007 3     2008-04-12T00:54:02Z   0 0 090000648048154f
FDA-2003-D-0030-0014 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Transcript of January 9, 2007 Workshop Other TR-Transcript 2007-03-21T04:00:00Z 2007 3     2008-04-12T00:54:04Z   0 0 0900006480481550
FDA-2003-D-0030-0015 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Transcript of January 9, 2007 Workshop Other TR-Transcript 2007-03-21T04:00:00Z 2007 3     2008-04-12T00:54:04Z   0 0 0900006480481551
FDA-2003-D-0030-0012 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 FDA Notice N-Notice 2006-12-20T05:00:00Z 2006 12     2008-04-12T00:54:03Z   0 0 090000648048154e
FDA-2003-D-0030-0011 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 FDA Notice NM-Notice of Meeting 2006-11-02T05:00:00Z 2006 11 2006-10-31T05:00:00Z   2008-04-12T00:54:01Z   0 0 0900006480481546
FDA-2003-D-0030-0009 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 GUIDANCE Supporting & Related Material GDL-Guidance 2006-06-16T04:00:00Z 2006 6     2008-04-12T00:54:04Z   0 0 0900006480481531
FDA-2003-D-0030-0010 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 FDA Notice NAD-Notice of Availability of Data 2006-06-16T04:00:00Z 2006 6 2006-06-08T04:00:00Z   2008-04-12T00:54:03Z   0 0 0900006480481532
FDA-2003-D-0030-0008 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 GUIDANCE Supporting & Related Material GDL-Guidance 2006-06-16T04:00:00Z 2006 6     2008-04-12T00:54:01Z   0 0 0900006480481530
FDA-2003-D-0030-0007 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Congressional Report: Feasibility and Cost of a New Monograph System for Marketed Unapproved Drugs Other RPT-Report (outside of agency unless indicated) 2006-06-07T04:00:00Z 2006 6     2008-04-12T00:54:02Z   0 0 090000648048152e
FDA-2003-D-0030-0005 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 GUIDANCE Supporting & Related Material GDL-Guidance 2004-03-05T05:00:00Z 2004 3     2008-04-12T00:54:02Z   0 0 0900006480481527
FDA-2003-D-0030-0006 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 FDA Notice NAD-Notice of Availability of Data 2004-03-05T05:00:00Z 2004 3 2004-02-27T05:00:00Z 2004-04-28T03:59:59Z 2008-04-12T00:54:04Z   0 0 0900006480481528
FDA-2003-D-0030-0001 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 FDA Notice NAD-Notice of Availability of Data 2003-10-23T04:00:00Z 2003 10 2003-10-20T04:00:00Z 2003-12-23T04:59:59Z 2008-04-12T00:54:01Z   0 0 0900006480481468
FDA-2003-D-0030-0002 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Guideline Supporting & Related Material GDL-Guidance 2003-10-23T04:00:00Z 2003 10     2008-04-12T00:54:03Z   0 0 0900006480481469
FDA-2003-D-0030-0003 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Guideline Supporting & Related Material GDL-Guidance 2003-10-23T04:00:00Z 2003 10     2008-04-12T00:54:01Z   0 0 090000648048146a
FDA-2003-D-0030-0004 FDA Guidance on Marketed Unapproved Drugs Compliance Policy Guide FDA-2003-D-0030 Guideline Supporting & Related Material GDL-Guidance 2003-10-23T04:00:00Z 2003 10     2008-04-12T00:54:01Z   0 0 090000648048146b

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);